# Melatonin for Nocturia in Parkinson's Disease

> **NCT02359448** · PHASE2 · UNKNOWN · sponsor: **University College, London** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease
- Nocturia

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT02359448
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359448, "Melatonin for Nocturia in Parkinson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02359448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*